KevinMD January 21, 2025
Jennifer Bath, PhD

Across all industries, artificial intelligence is changing our approach to developing new products, including in the life sciences and drug development. While it may seem that an AI-derived treatment is far in the future, the science, biomathematics, and computational power needed to discover and test these compounds are advancing at a rapid pace. AI is the new, better way to more quickly and accurately identify the next big drug candidate.

How AI is speeding up drug development

Until recently, new drug candidates were almost discovered by accident, after researchers experimented in the lab with a hypothesis in mind, but one that needed to be tested with time-consuming trial and error. Traditionally, it takes 10 to 15 years on average to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Technology
‘Humphrey’ AI tool launched to streamline NHS and public services
Oracle shares jump 7% on involvement in AI infrastructure initiative that Trump will announce
Cofactor AI Launches Platform to Help Hospitals Fight Tidal Wave of Claims Denials and Announces $4 Million Seed Round
5 Healthcare AI Trends in 2025: Balancing Innovation and Patient Safety
Do We Need Humans in the Loop? A Novo Nordisk Exec Weighs In (Video)

Share This Article